INVO Fertility, Inc. (IVF) Income Statement
IVF 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsIVF revenue and net income
Where IVF's revenue goes
2025Each bar shows an amount and its share of revenue. IVF kept −340.9% of revenue as net income.
IVF profit margins
IVF growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +4.7% | +102.6% | +45.8% | +89.1% |
| Gross profit | −12.0% | — | +21.7% | +91.2% |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
IVF quarterly EPS vs estimates
INVO Fertility beat the analyst EPS estimate in 2 of the last 4 quarters. Next report: November 16, 2026.
IVF income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.8M | $6.5M | $3.0M | $822,196 | $4.2M | $1.0M | $1.5M | $494,375 | $282,145 | $50,901 |
| Cost of revenue | $4.3M | $3.7M | $1.9M | $850,770 | $145,052 | $88,760 | $139,670 | $90,367 | $51,954 | $15,094 |
| Gross profit | $2.5M | $2.9M | $1.1M | −$28,574 | $4.0M | $948,526 | $1.3M | $404,008 | $230,191 | $35,807 |
| Research & development | $0 | $489,660 | $165,945 | $544,043 | $216,430 | $398,426 | — | — | — | — |
| Sales, general & admin | $7.7M | $9.1M | $7.5M | $10.0M | $9.0M | $6.1M | — | — | — | — |
| Total operating expenses | $8.4M | $11.0M | $7.9M | $10.6M | $9.2M | $6.5M | $3.1M | $3.0M | $870,612 | $2.1M |
| Operating income | −$5.8M | −$8.1M | −$6.8M | −$10.6M | −$5.2M | −$5.5M | −$1.8M | −$2.6M | −$640,421 | −$2.1M |
| Interest income | — | — | $0 | $308 | $3,657 | $4,190 | — | — | — | — |
| Interest expense | $1.3M | $1.1M | $925,909 | $59,445 | $1.3M | $2.8M | $379,019 | $442,031 | $20,873 | $13,838 |
| Income before taxes | −$5.5M | −$9.1M | −$8.0M | −$10.9M | −$6.7M | −$8.3M | −$2.2M | −$3.1M | −$702,163 | −$2.1M |
| Income taxes | −$150,371 | −$22,913 | $27,786 | $2,872 | $4,764 | $36 | $433 | — | — | — |
| Net income | −$23.3M | −$9.1M | −$8.0M | −$10.9M | −$6.7M | −$8.3M | −$2.2M | −$3.1M | −$702,163 | −$2.1M |
| EBITDA | −$3.5M | −$7.1M | −$6.9M | −$10.8M | −$5.2M | −$5.5M | −$1.8M | −$2.6M | −$678,480 | −$2.1M |
| EPS (diluted) | −$1093.64 | −$3202.78 | — | — | −$13.00 | −$17.05 | −$252.65 | −$4768.09 | −$4580.13 | −$14103.67 |
| Gross margin | 37.0% | 44.0% | 36.0% | −3.5% | 96.5% | 91.4% | 90.6% | 81.7% | 81.6% | 70.3% |
| Operating margin | −85.4% | −124.4% | −224.0% | −1,292.5% | −125.4% | −531.7% | −120.8% | −532.8% | −227.0% | −4,146.1% |
| Net margin | −340.9% | −139.3% | −266.0% | −1,324.8% | −160.0% | −804.7% | −146.4% | −622.2% | −248.9% | −4,173.3% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.2M | $2.0M | $1.6M | $1.8M | $1.9M | $1.6M | $1.7M | $1.4M | $1.8M | $1.6M | $1.4M | $974,894 |
| Cost of revenue | $1.6M | $1.3M | $1.0M | $1.1M | $1.1M | $1.0M | $957,419 | $988,465 | $861,648 | $850,234 | $886,750 | $580,968 |
| Gross profit | $617,100 | $727,826 | $536,860 | $629,345 | $770,051 | $592,256 | $728,547 | $444,686 | $974,949 | $726,052 | $495,004 | $393,926 |
| Research & development | — | — | $0 | $0 | $0 | $265,663 | $484,780 | $171,224 | $0 | $4,880 | $5,907 | $2,668 |
| Sales, general & admin | $1.9M | $2.2M | $1.8M | $2.1M | $2.2M | $2.6M | $3.5M | $1.5M | $2.6M | $1.4M | $1.9M | $1.3M |
| Total operating expenses | $1.9M | $2.3M | $3.0M | $2.3M | $2.4M | $3.1M | $4.7M | $1.7M | $2.9M | $1.7M | $2.0M | $1.3M |
| Operating income | −$1.3M | −$1.6M | −$1.4M | −$1.6M | −$1.6M | −$2.5M | −$4.0M | −$1.3M | −$1.9M | −$946,374 | −$1.5M | −$886,290 |
| Interest income | $139,514 | — | — | — | $0 | — | — | — | — | — | $0 | $0 |
| Interest expense | $177,227 | $180,323 | $627,107 | $145,803 | $221,325 | $311,270 | $231,824 | $273,629 | $369,612 | $181,295 | $182,043 | $352,085 |
| Income before taxes | $944,894 | −$5.5M | $1.9M | −$2.6M | −$3.2M | −$17.4M | −$3.7M | −$1.6M | −$2.2M | −$1.6M | −$2.0M | −$1.2M |
| Income taxes | $56,154 | −$150,371 | — | — | — | — | −$54,008 | $29,259 | — | $1,836 | $23,035 | $1,886 |
| Net income | $888,740 | −$5.5M | $2.0M | −$2.6M | −$5.3M | −$17.4M | −$3.6M | −$1.6M | −$2.2M | −$1.6M | −$2.0M | −$1.2M |
| EBITDA | −$1.1M | −$5.2M | $2.6M | −$2.4M | −$2.8M | −$16.9M | −$3.2M | −$1.1M | −$1.6M | −$1.2M | −$1.6M | −$873,969 |
| EPS (diluted) | $0.35 | −$3.38 | — | −$0.77 | −$8.07 | −$1084.80 | −$1084.80 | −$604.26 | −$895.63 | −$604.70 | — | −$0.70 |
| Gross margin | 28.4% | 36.1% | 33.9% | 35.8% | 41.3% | 36.2% | 43.2% | 31.0% | 53.1% | 46.1% | 35.8% | 40.4% |
| Operating margin | −59.3% | −78.9% | −89.2% | −93.1% | −85.5% | −150.4% | −235.8% | −90.7% | −103.6% | −60.0% | −109.2% | −90.9% |
| Net margin | 40.9% | −274.9% | 126.9% | −150.5% | −283.6% | −1,063.0% | −214.9% | −113.8% | −122.2% | −101.3% | −144.4% | −128.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in IVF's financial statements (latest annual report filed June 2, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
IVF financial results
In fiscal year 2025 (ended December 31, 2025), INVO Fertility reported revenue of $6.8 million, up 4.7% from the year before. It had a net loss of $23.3 million, a net profit margin of −340.9%. Diluted earnings per share came to −$1093.64. Over five years revenue grew at an average rate of 45.8% a year.
See the IVF stock overview for the latest quote and news, or the IVF chart for price history and technical indicators.
IVF income statement FAQ
What is INVO Fertility's annual revenue?
INVO Fertility reported total revenue of $6.8 million for fiscal year 2025, which ended on December 31, 2025. That was up 4.7% from $6.5 million the previous year.
Is INVO Fertility profitable?
No. INVO Fertility reported a net loss of $23.3 million in fiscal 2025, a net profit margin of −340.9%; its operating margin was −85.4%.
What is INVO Fertility's gross margin?
INVO Fertility's gross margin was 37.0% in fiscal 2025: for every $100 of revenue, INVO Fertility kept $37 after the direct cost of its products and services.
How fast is INVO Fertility growing?
Revenue grew 45.8% a year on average over the last five fiscal years, from $1.0 million to $6.8 million.
What are INVO Fertility's earnings per share?
INVO Fertility earned $-1093.64 per diluted share in fiscal 2025, compared with $-3202.78 a year earlier.
When will INVO Fertility report its next earnings?
INVO Fertility is expected to report results for the quarter ending September 30, 2026 on November 16, 2026.
When does INVO Fertility's fiscal year end?
INVO Fertility's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on June 2, 2026.